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Introduction
High levels of HTLV-1 proviral load in peripheral blood
mononuclear cells (PBMCs) have been observed in
patients with Adult T-cell Leukaemia Lymphoma
(ATLL) and HTLV-1 Associated Myelopathy/Tropical
Spastic Paraparesis (HAM/TSP). The proviral load has
been reported to fluctuate in both asymptomatic carriers
and in symptomatic patients. We aimed to quantify
intra-patient variability, to identify “outliers”,a n dt o
characterise the range of viral loads in asymptomatic
carriers and in patients with HTLV-1-associated
diseases.
Methods
Viral loads were quantified using a SYBR Green-based
real-time quantitative polymerase chain reaction, and
expressed as a percentage of infected PBMCs.
Results
1. Mean viral loads were significantly different between
asymptomatic carriers and HAM/TSP (p<0.001), and
between asymptomatic carriers and ATLL (p=0.001);
2. Viral loads below 1% were found only in asympto-
matic carriers;
3. 15% of asymptomatic carriers had a viral load >10%,
3% >20%;
4. The intra-assay CV increases as viral load decreases;
5 .T h ei n t e r - a s s a yC Va tl o wl o a d si sn o td i f f e r e n t
from the intra-assay CV;
6. Mean intra-patient CV is 65% (SD 21) in asympto-
matic carriers, and 51% (23) in HAM/TSP.
Discussion
HTLV-1 viral load is highly variable between infected
patients. We speculate that asymptomatic carriers with a
viral load higher than 10% are more likely to develop
HTLV-1 associated diseases. We suggest the use of
intra-patient variability (CV) to identify significant varia-
tions in viral load, that would allow the identification of
patients who may be developing an associated disease,
or to assess the efficacy of treatments to reduce viral
load.
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